Abstract:Objective To compare the effects of intra-amniotic and maternal intramuscular injection of glucocorticoid on fetal lung maturity and blood glucose level in gestational diabetes mellitus (GDM) and pregestational diabetes mellitus (PGDM).Methods A total of 60 GDM and PGDM women,whose blood glucose control was inadequate and who needed glucocorticoid treatment for fetal lung maturity,were selected in Peking University First Hospital from January 2013 to April 2015.They received intramuscular (29 women) or intraamniotic (31 women) injection of dexamethasone.Amniotic fluid samples were collected from the two groups during cesarean section for the oscillation test and for determining the surfactant protein-A level.Outcome of the neonates was followed up.Their blood glucose levels and after treatment,fetal lung maturity and neonatal outcomes were analyzed and compared.Two-sample t test,sum-rank,Chi-square and Fisher exact tests were used for statistical analysis.Results (1) Before treatment,the intra-amniotic injection group had a higher preprandial blood glucose level than intramuscular injection group [(5.8 ± 0.6) vs (5.3 ± 0.7) mmol/L,t=-2.730,P=0.008].On the first day after treatment,preprandial blood glucose level in intramuscular injection group was (6.5 ±0.8) mmol/L,and elevated by (1.2±0.9) mmol/L compared with before treatment;preprandial blood glucose in intra amniotic injection group was (6.7± 1.3) mmol/L,and increased by (1.1 ± 1.2) mmol/L.There was no statistical difference in the increment of preprandial blood glucose between the two groups (t=0.548,P=0.586).On the second day after treatment,preprandial blood glucose in intramuscular injection group was higher than before treatment (t=9.070,P=0.000),while preprandial blood glucose in intra-amniotic injection group restored to the pre-treatment level (t=0.516,P=0.612),and preprandial blood glucose in intramuscular injection group was higher than in intra-amniotic injection group [(6.9±0.9) vs (5.6±0.8) mmol/L,t=4.676,P=0.000].On the third day after treatment,preprandial blood glucose in intramuscular injection group decreased to (5.7±0.4) mmol/L,but was still higher than before treatment (t=3.000,P=0.034),while there were no differences in intra-amniotic injection group compared with the level before treatment [(5.9±2.0) vs (5.8± 0.6) mmol/L,t=-0.226,P=0.826].The preprandial and postprandial blood glucose showed a similar trend of change in the two groups.(2) There were no differences in the mature rate [86％ (24/28) vs 88％ (23/26),Fisher exact test] by the oscillation test and surfactant protein-A level [(1 489.1 ±669.3) vs (1 495.2±535.7) μ g/L,t=-0.037],the gender ratio,birth weight,and incidences of macrosomia,neonatal asphyxia,hypoglycemia and hyperbilirubinemia between intramuscular injection group and intra-amniotic injection group (all P＞0.05).No neonatal respiration distress syndrome occurred in the two groups.Conclusions Intra-amniotic injection and intramuscular injection of dexamethasone have the same effects on elevating maternal blood glucose level,but the duration of the effects of intra-amniotic injection is shorter.

Effect of Pregnancies with Abnormal Glucose Metabolism on Fetal Lung Maturity

P06.07: Multiple Fetal Echocardiographic Parameters for Evaluation of Fetal Left Ventricular Diastolic Function in Women with Gestational Glucose Metabolic Abnormalities

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Changes in Maternal Glucose Metabolism after the Administration of Dexamethasone for Fetal Lung Development

Relationship of Abnormal Mid-Term Oral Glucose Tolerance Test and Maternal Weight Gain with Adverse Pregnancy Outcomes in Women with Gestational Diabetes Mellitus

Analysis on the outcomes of 162 maternal and fetal with abnormal glucose metabolism during pregnancy

Growth Pattern at Infantile Period in Offsprings of Mothers with Abnormal Glucose Metabolism During Pregnancy

Adverse Maternal and Neonatal Outcomes in Pregnant Women with Abnormal Glucose Metabolism.

Effect of Maternal Lipid Profile, C-peptide, Insulin, and HBA1c Levels During Late Pregnancy on Large-for-gestational Age Newborns

Relationship Between Blood Lipid Levels of Pregnant Women with Glucose Metabolism Disorders and Perinatal Outcomes

Maternal Glycemia During Pregnancy and Child Lung Function: A Prospective Cohort Study

Research on the Effect of Glucose Tolerance Screening on the Prognosis of Mothers and Infants in Different Gestational Ages

24 hours blood glucose monitoring in newborns of abnormal glucose metabolic pregnant women

Decreased Fetal Pre-Adipocyte Factor-1 in Pregnancies Complicated by Gestational Diabetes Mellitus

Association between Variation of Maternal Glucose Concentration and Pregnant outcome in Pregnant Women with Normal Glucose Tolerance Test

Relationship between lipid metabolism and pregnant outcomes in women with abnormal gestational glucose metabolism

Maternal Pregestational Glucose Level and Adverse Neonatal Outcomes: a Population-Based Retrospective Cohort Study

Effects of gestational diabetes mellitus on the growth rate of fetuses

Blood Sugar Management in Delivery for Pregnant Women with Abnormal Glucose Metabolism Associated with Neonatal Hypoglycemia

Effects of Intra-Amniotic and Maternal Intramuscular Injection of Glucocorticoid on Fetal Lung Maturity and Blood Glucose Level in Women with Gestational Diabetes Mellitus

Effect of Maternal Glucose and Triglyceride Levels During Early Pregnancy on Pregnancy Outcomes: A Retrospective Cohort Study